Targeted protein degradation is staying explored as an alternative method in cancer, whereby the pure protein degradation method is co-opted for therapeutic purposes. A short while ago formulated novel molecules named proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. One ligand binds to the ‘protein https://www.directivepublications.org/journal-of-clinical-breast-cancer/